Today: 21 May 2026
NIO stock today: Shares slide in premarket after record 2025 deliveries
2 January 2026
1 min read

NIO stock today: Shares slide in premarket after record 2025 deliveries

New York, January 2, 2026, 07:28 ET — Premarket

U.S.-listed shares of Nio Inc were down 41 cents, or about 7.4%, at $5.10 in premarket trading on Friday. Peer China EV makers XPeng and Li Auto were also lower, down about 4.7% and 2.0%, respectively.

The move comes after Nio reported record December and fourth-quarter deliveries, a closely watched read-through on demand as China’s EV makers start the year by resetting volume targets and price strategies. Nio said it delivered 48,135 vehicles in December and 124,807 in the fourth quarter, taking 2025 deliveries to 326,028, with cumulative deliveries at 997,592 as of Dec. 31.

Monthly delivery updates matter because they arrive well before quarterly earnings and can shift expectations for revenue and production ramps. Investors are also weighing whether strong shipment growth can translate into better margins in a market still defined by heavy discounting and fast model cycles.

Nio’s delivery release also broke out results across its brands, highlighting the pace of scaling beyond its original premium line. The company said its NIO brand delivered 31,897 vehicles in December, while Onvo delivered 9,154 and Firefly delivered 7,084, with quarterly and full-year breakdowns also showing a larger contribution from the newer lines.

Founder and CEO William Li flagged near-term milestones in an internal staff letter reported on Friday, including a production marker and expanded infrastructure plans. “In just a few days, we will celebrate the rollout of our one-millionth mass-produced vehicle,” Li wrote, and he also outlined plans for broader international expansion and a larger battery-swap buildout in 2026. CnEVPost

Rival delivery updates released around the same time underscored how crowded the year-end sprint has become among China’s U.S.-listed EV names. XPeng said it delivered 37,508 vehicles in December and 429,445 for full-year 2025, while Li Auto said it delivered 44,246 vehicles in December and 109,194 in the fourth quarter.

Bigger players are also showing signs of demand volatility as the market matures. BYD said December sales fell 18.3% from a year earlier, while its 2025 sales growth slowed to the weakest pace in five years, according to calculations based on company data reported by Reuters.

Nio’s premarket drop despite record deliveries suggests traders are treating the volume print as only one piece of the puzzle. The next debate is whether higher shipments came with heavier incentives, and how that will show up in gross margin and cash flow when quarterly results arrive.

Investors will also watch whether Nio can sustain the pace after a strong fourth quarter, especially as competitors roll out refreshes and expand abroad. Monthly deliveries in early 2026 will be a key checkpoint for whether year-end momentum was seasonal or structural.

Before the U.S. regular session opens at 9:30 a.m. ET, the stock is hovering near the $5 level — a round-number area that often draws short-term trading interest. Any reversal in China EV peers could also matter, given the group’s tendency to trade as a basket on sentiment swings.

Stock Market Today

  • Scotiabank Shares Showing 32% Undervaluation at C$108 Amid Strong Returns
    May 20, 2026, 10:05 PM EDT. Scotiabank (TSX:BNS) stock has rallied to around C$108.50, delivering a 59.4% return over the past year and nearly 79% over five years highlighting strong performance. Despite this, valuation models suggest substantial remaining upside. Simply Wall St's Excess Returns analysis estimates the bank's intrinsic value at approximately C$160 per share, indicating it is 32.2% undervalued compared to current prices. This model calculates excess returns by comparing the bank's return on equity to its cost of equity, reflecting efficient shareholder profit generation. Investors are closely watching key fundamentals including balance sheet resilience and dividend yield as Scotiabank navigates evolving interest rate environments. The stock's valuation score of 4 out of 6 suggests moderate confidence among analysts that price gains can continue.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus
Previous Story

SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus

ASML shares jump after surprise Aletheia upgrade flips outlook on EUV demand
Next Story

ASML shares jump after surprise Aletheia upgrade flips outlook on EUV demand

Go toTop